NR-52201鲍曼不动杆菌,MRSN16880(细菌）
产品图片
货号/SKU
NR-52201
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类：美国、2
产品描述信息
NR-52201??Acinetobacter baumannii, MRSN 16880(Bacteria)|Acinetobacter baumannii|MRSN 16880|-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 16880, NR-52201. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Acinetobacter baumannii (A. baumannii), strain MRSN 16880 was isolated in 2011 from a human blood sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 16880 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52201 was deposited as multi-locus sequence type (MLST) ST 10, sensitive to ceftazidime, colistin, ceftriaxone, cefepime, imipenem, ampicillin/sulbactam and meropenem, intermediately resistant to amikacin and tobramycin, and resistant to ciprofloxacin, gentamicin, levofloxacin, tetracycline and trimethoprim/sulfamethoxazole. Strain MRSN 16880 is reported to have three aminoglycoside transferase genes [aac(3)-IId, aph(3'')-Ib and aph(3')-VIb; conferring resistance to various aminoglycosides], five beta-lactamase genes (blaADC-25, blaCARB-2, blaCARB-4, blaOXA-58 and blaOXA-68; conferring resistance to beta-lactams), one dihydrofolate reductase gene (dfrA16; conferring resistance to trimethoprim), one macrolide phosphotransferase gene [mph(E); conferring resistance to macrolide antibiotics], one ABC-F subfamily protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics], one sulfonamide resistance gene (sul1; conferring resistance to sulfonamides) and one tetracycline resistance gene [tet(39); conferring resistance to tetracycline]. The complete genome of A. baumannii, strain MRSN 16880 is available (GenBank: VHGO00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Acinetobacter baumannii (A. baumannii), strain MRSN 16880 was isolated in 2011 from a human blood sample in the United States as part of a global surveillance program.
A. baumannii, strain MRSN 16880 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52201 was deposited as multi-locus sequence type (MLST) ST 10, sensitive to ceftazidime, colistin, ceftriaxone, cefepime, imipenem, ampicillin/sulbactam and meropenem, intermediately resistant to amikacin and tobramycin, and resistant to ciprofloxacin, gentamicin, levofloxacin, tetracycline and trimethoprim/sulfamethoxazole. Strain MRSN 16880 is reported to have three aminoglycoside transferase genes [aac(3)-IId, aph(3'')-Ib and aph(3')-VIb; conferring resistance to various aminoglycosides], five beta-lactamase genes (blaADC-25, blaCARB-2, blaCARB-4, blaOXA-58 and blaOXA-68; conferring resistance to beta-lactams), one dihydrofolate reductase gene (dfrA16; conferring resistance to trimethoprim), one macrolide phosphotransferase gene [mph(E); conferring resistance to macrolide antibiotics], one ABC-F subfamily protein gene [msr(E); conferring resistance to erythromycin and streptogramin B antibiotics], one sulfonamide resistance gene (sul1; conferring resistance to sulfonamides) and one tetracycline resistance gene [tet(39); conferring resistance to tetracycline]. The complete genome of A. baumannii, strain MRSN 16880 is available (GenBank: VHGO00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
AcineTobacter Baumannii（A.Baumannii），菌株MRSN 16880于2011年从美国的人血样品中分离，作为全球监测计划的一部分.
a. Baumannii ，菌株MRSN 16880作为MRSN 鲍曼杆菌的一部分沉积，Baumannii 从BEI资源作为NR-52248获得的多样性面板. NR-52201沉积为多基因座序列类型（MLST）ST 10，对Ceftazidime，Colistin，Ceftriaxone，Cefepime，ImipeNem，氨苄青霉素/抑制蛋白和梅洛宁，中间耐抗Amikacin和杂草蛋白，并抵抗Ciprofloxacin，庆大霉素，百氟葡萄嘧啶，四环素和三甲基氯嘧啶/磺胺甲恶唑.据报道，菌株MRSN 16880具有三种氨基糖苷类转移酶基因[ AAC （3）-iId， APH （3'） - IB和 APH （3'） - vib;赋予各种氨基糖苷的抗性，五β-内酰胺酶基因（ BLA ADC-25 ， BLA Carb-2 ， bla carb-4 ， bla oxa-58 和 bla Oxa-68 ;赋予β-内酰胺酸酯，一种二羟氢酯还原酶基因（ DFR-i> A16;赋予Trimethokim的抵抗力），一种大环内德磷酸转移酶基因[ Mph （e）;赋予大环内酯抗生素的抗性]，一种ABC-F亚家族蛋白基因[ MSR（ e）;赋予红霉素和链图B抗生素的抗性，一种磺酰胺抗性基因（ Sul 1;赋予磺胺酰胺抗性）和一种四环素抗性基因[ TET （39）;赋予四环素的抵抗力. a的完整基因组. Baumannii ，应变MRSN 16880可用（Genbank： vhgo00000000 ）. >
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养，补充有10％甘油.
patric （Pathosystems资源集成中心）提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。
除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
可能感兴趣的内容
2022-04-01
2024-08-18
2022-04-01
2021-12-21
2022-04-01
2020-08-04
2024-05-12
2024-11-06
2022-01-10
2022-04-01
2022-04-01
2022-04-01
2022-04-01